Kießling, M., Oberholzer, P. A., Mondal, C., Karpova, M. B., Zipser, M. C., Lin, W. M., . . . Dummer, R. (2011). High-throughput mutation profiling of CTCL samples reveals KRAS and NRAS mutations sensitizing tumors toward inhibition of the RAS/RAF/MEK signaling cascade. Blood, 117(8), . https://doi.org/10.1182/blood-2010-09-305128
Chicago-Zitierstil (17. Ausg.)Kießling, Michael, et al. "High-throughput Mutation Profiling of CTCL Samples Reveals KRAS and NRAS Mutations Sensitizing Tumors Toward Inhibition of the RAS/RAF/MEK Signaling Cascade." Blood 117, no. 8 (2011). https://doi.org/10.1182/blood-2010-09-305128.
MLA-Zitierstil (9. Ausg.)Kießling, Michael, et al. "High-throughput Mutation Profiling of CTCL Samples Reveals KRAS and NRAS Mutations Sensitizing Tumors Toward Inhibition of the RAS/RAF/MEK Signaling Cascade." Blood, vol. 117, no. 8, 2011, https://doi.org/10.1182/blood-2010-09-305128.